152 related articles for article (PubMed ID: 3514341)
1. Islet cell antibodies and the development of diabetes mellitus in relation to mumps infection and mumps vaccination.
Helmke K; Otten A; Willems WR; Brockhaus R; Mueller-Eckhardt G; Stief T; Bertrams J; Wolf H; Federlin K
Diabetologia; 1986 Jan; 29(1):30-3. PubMed ID: 3514341
[TBL] [Abstract][Full Text] [Related]
2. Islet cell antibodies and viral infections.
Federlin K; Otten A; Helmke K
Exp Clin Endocrinol; 1987 Aug; 89(3):368-74. PubMed ID: 3311779
[TBL] [Abstract][Full Text] [Related]
3. Mumps, mumps vaccination, islet cell antibodies and the first manifestation of diabetes mellitus type I.
Otten A; Helmke K; Stief T; Mueller-Eckhard G; Willems WR; Federlin K
Behring Inst Mitt; 1984 Jul; (75):83-8. PubMed ID: 6385957
[TBL] [Abstract][Full Text] [Related]
4. Islet cell antibodies, mumps infection and mumps vaccination.
Vaandrager GJ; Molenaar JL; Bruining GJ; Plantinga AD; Ruitenberg EJ
Diabetologia; 1986 Jun; 29(6):406-7. PubMed ID: 3527840
[No Abstract] [Full Text] [Related]
5. Complications of mumps infection, islet-cell antibodies, and HLA.
Mueller-Eckhardt G; Stief T; Otten A; Helmke K; Willems WR; Mueller-Eckhardt C
Immunobiology; 1984 Oct; 167(4):338-44. PubMed ID: 6392072
[TBL] [Abstract][Full Text] [Related]
6. Previous exposure to measles, mumps, and rubella--but not vaccination during adolescence--correlates to the prevalence of pancreatic and thyroid autoantibodies.
Lindberg B; Ahlfors K; Carlsson A; Ericsson UB; Landin-Olsson M; Lernmark A; Ludvigsson J; Sundkvist G; Ivarsson SA
Pediatrics; 1999 Jul; 104(1):e12. PubMed ID: 10390298
[TBL] [Abstract][Full Text] [Related]
7. Complement-mediated cytotoxic effects of islet cell surface antibodies in non-diabetic subjects with antecedent mumps infection and diabetic risk.
Ratzmann KP; Jahr H; Richter KV
Exp Clin Endocrinol; 1988 May; 91(2):176-82. PubMed ID: 3044806
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of islet cell antibodies (ICA) and islet cell surface antibodies (ICSA) in children and adolescents with antecedent mumps infection).
Ratzmann KP; Strese J; Rjasanowski I; Witt S; Keilacker H
Exp Clin Endocrinol; 1984 Apr; 83(2):199-202. PubMed ID: 6539220
[TBL] [Abstract][Full Text] [Related]
9. Metabolic, hormonal, and immunological alterations in subjects with antecedent mumps infection.
Ratzmann KP; Strese J; Rjasanowski I; Witt S; Kohnert KD; Keilacker H; Richter KV; Giebelmann R; Schulz B
Exp Clin Endocrinol; 1985 Dec; 86(3):323-34. PubMed ID: 3912201
[TBL] [Abstract][Full Text] [Related]
10. Mumps infection and insulin-dependent diabetes mellitus (IDDM).
Ratzmann KP; Strese J; Witt S; Berling H; Keilacker H; Michaelis D
Diabetes Care; 1984; 7(2):170-3. PubMed ID: 6376012
[TBL] [Abstract][Full Text] [Related]
11. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
12. Relationship between serum insulin autoantibodies, islet cell antibodies and Coxsackie-B4 and mumps virus-specific antibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes.
Karjalainen J; Knip M; Hyöty H; Leinikki P; Ilonen J; Käär ML; Akerblom HK
Diabetologia; 1988 Mar; 31(3):146-52. PubMed ID: 3286341
[TBL] [Abstract][Full Text] [Related]
13. Islet cell surface antibodies (ICSA) in subjects with a previous mumps infection--a prospective study over a 4 year period.
Schulz B; Michaelis D; Hildmann W; Witt S; Hehmke B; Rjasanowski I
Exp Clin Endocrinol; 1987 Aug; 90(1):62-70. PubMed ID: 3311781
[TBL] [Abstract][Full Text] [Related]
14. Difficulties in assessing the relationship, if any, between mumps vaccination and diabetes mellitus in childhood.
Milne LM
Vaccine; 2000 Dec; 19(9-10):1018-25. PubMed ID: 11137235
[TBL] [Abstract][Full Text] [Related]
15. [Cytoplasmic islet-cell antibodies (ICA) and cytoplasmic complement- fixing antibodies (CF-ICA) in patients with newly detected and short-lasting diabetes mellitus type 1].
Majkowska L; Czekalski S; Skwira J
Pol Tyg Lek; 1990 May 7-14; 45(19-20):384-8. PubMed ID: 2255656
[TBL] [Abstract][Full Text] [Related]
16. [Islet cell cytoplasmic antibodies (ICA) and complement-fixing islet cell cytoplasmic antibodies (CF-ICA) in patients with newly detected type 1 diabetes mellitus of short duration].
Majkowska L
Ann Acad Med Stetin; 1990; 36():95-111. PubMed ID: 2099111
[TBL] [Abstract][Full Text] [Related]
17. Virus infection islet cell antibodies and islet cell function in type I diabetes mellitus.
Helmke K; Brockhaus R; Seitz M; Otten H; Willems WR; Laube H; Federlin K
Behring Inst Mitt; 1984 Jul; (75):73-82. PubMed ID: 6385956
[TBL] [Abstract][Full Text] [Related]
18. Decline of mumps antibodies in type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland. Childhood Diabetes in Finland Study Group.
Hyöty H; Hiltunen M; Reunanen A; Leinikki P; Vesikari T; Lounamaa R; Tuomilehto J; Akerblom HK
Diabetologia; 1993 Dec; 36(12):1303-8. PubMed ID: 8307260
[TBL] [Abstract][Full Text] [Related]
19. Islet cell antibodies in children with mumps infection.
Helmke K; Otten A; Willems W
Lancet; 1980 Jul; 2(8187):211-2. PubMed ID: 6105384
[No Abstract] [Full Text] [Related]
20. Epidemiology and inmunogenetics in recently diagnosed Venezuelan children with insulin-dependent diabetes mellitus.
Gunczler P; Lanes R; Layrisse Z; Esparza B; Salas R; Hernández L; Arnaiz-Villena A
J Pediatr Endocrinol; 1993; 6(2):165-71. PubMed ID: 8394177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
